BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19255117)

  • 21. Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy.
    Naitoh J; Kaplan A; Dorey F; Figlin R; Belldegrun A
    J Urol; 1999 Jul; 162(1):46-50. PubMed ID: 10379737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pathological prognostic indicators in renal cell carcinoma].
    Rey Rey J; León Ramírez D; López García S; Fernández Vázquez P; Benavente Delgado J; Ojea Calvo A
    Actas Urol Esp; 2010 Jan; 34(1):71-7. PubMed ID: 20223135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
    Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
    Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of a postoperative prognostic model consisting of tumor microvascular invasion, size, and grade to predict disease-free and cancer-specific survival of patients with surgically resected renal cell carcinoma.
    May M; Brookman-Amissah S; Kendel F; Knoll N; Roigas J; Hoschke B; Miller K; Gilfrich C; Pflanz S; Gralla O
    Int J Urol; 2009 Jul; 16(7):616-21. PubMed ID: 19456988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of renal embolization in patients with synchronous metastatic renal cell carcinoma: a retrospective comparison of cytoreductive nephrectomy and systemic medical therapy.
    Kim SH; Kim JK; Park B; Joo J; Joung JY; Seo HK; Lee KH; Chung J
    Oncotarget; 2017 Jul; 8(30):49615-49624. PubMed ID: 28548948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perioperative blood transfusion adversely affects prognosis after nephrectomy for renal cell carcinoma.
    Abu-Ghanem Y; Zilberman DE; Dotan Z; Kaver I; Ramon J
    Urol Oncol; 2018 Jan; 36(1):12.e15-12.e20. PubMed ID: 28993059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Results of catheter embolization of renal cell carcinoma].
    Vogel J; Görich J; von Ahlen H; Harder T; Friedrich JM; Rilinger N; Merkle E; Brambs HJ
    Aktuelle Radiol; 1995 Sep; 5(5):301-4. PubMed ID: 7495892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laparoscopic and open partial nephrectomy: a matched-pair comparison of 200 patients.
    Marszalek M; Meixl H; Polajnar M; Rauchenwald M; Jeschke K; Madersbacher S
    Eur Urol; 2009 May; 55(5):1171-8. PubMed ID: 19232819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
    Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
    Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The impact to operation safety of preoperative renal artery embolization for management of diameter≥10 cm renal cell carcinoma].
    Jia Z; Li XS; Zhang CJ; Yang KW; Peng D; Yang JH; Ding CM; Xi CG; He ZS; Zhou LQ
    Zhonghua Wai Ke Za Zhi; 2017 Oct; 55(10):738-741. PubMed ID: 29050172
    [No Abstract]   [Full Text] [Related]  

  • 31. Renal artery embolisation in the palliative treatment of renal carcinoma.
    Maxwell NJ; Saleem Amer N; Rogers E; Kiely D; Sweeney P; Brady AP
    Br J Radiol; 2007 Feb; 80(950):96-102. PubMed ID: 17495058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-operative acute kidney injury in patients with renal cell carcinoma is a potent risk factor for new-onset chronic kidney disease after radical nephrectomy.
    Cho A; Lee JE; Kwon GY; Huh W; Lee HM; Kim YG; Kim DJ; Oh HY; Choi HY
    Nephrol Dial Transplant; 2011 Nov; 26(11):3496-501. PubMed ID: 21406544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A systematic review and meta-analysis on the efficacy of preoperative renal artery embolization prior to radical nephrectomy for renal cell carcinoma: Is it necessary?
    Rooseno G; Hakim L; Djojodimedjo T
    Arch Ital Urol Androl; 2023 Dec; 95(4):12018. PubMed ID: 38058293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiofrequency ablation versus radical nephrectomy: clinical outcomes for stage T1b renal cell carcinoma.
    Takaki H; Soga N; Kanda H; Nakatsuka A; Uraki J; Fujimori M; Yamanaka T; Hasegawa T; Arima K; Sugimura Y; Sakuma H; Yamakado K
    Radiology; 2014 Jan; 270(1):292-9. PubMed ID: 23925272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population.
    Neuzillet Y; Tillou X; Mathieu R; Long JA; Gigante M; Paparel P; Poissonnier L; Baumert H; Escudier B; Lang H; Rioux-Leclercq N; Bigot P; Bernhard JC; Albiges L; Bastien L; Petit J; Saint F; Bruyere F; Boutin JM; Brichart N; Karam G; Branchereau J; Ferriere JM; Wallerand H; Barbet S; Elkentaoui H; Hubert J; Feuillu B; Theveniaud PE; Villers A; Zini L; Descazeaux A; Roupret M; Barrou B; Fehri K; Lebret T; Tostain J; Terrier JE; Terrier N; Martin L; Dugardin F; Galliot I; Staerman F; Azemar MD; Irani J; Tisserand B; Timsit MO; Sallusto F; Rischmann P; Guy L; Valeri A; Deruelle C; Azzouzi AR; Chautard D; Mejean A; Salomon L; Rigaud J; Pfister C; Soulié M; Kleinclauss F; Badet L; Patard JJ; ;
    Eur Urol; 2011 Aug; 60(2):366-73. PubMed ID: 21377780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative metastatic status, level of thrombus and body mass index predict overall survival in patients undergoing nephrectomy and inferior vena cava thrombectomy.
    Spiess PE; Kurian T; Lin HY; Rawal B; Kim T; Sexton WJ; Pow-Sang JM
    BJU Int; 2012 Dec; 110(11 Pt B):E470-4. PubMed ID: 22519938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical treatment of atypical metastasis from renal cell carcinoma (RCC).
    Antonelli A; Arrighi N; Corti S; Legramanti S; Zanotelli T; Cozzoli A; Cunico SC; Simeone C
    BJU Int; 2012 Dec; 110(11 Pt B):E559-63. PubMed ID: 22639956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nephrectomy improves the survival of patients with locally advanced renal cell carcinoma.
    Zini L; Perrotte P; Jeldres C; Capitanio U; Pharand D; Arjane P; Lapointe S; Montorsi F; Patard JJ; Karakiewicz PI
    BJU Int; 2008 Dec; 102(11):1610-4. PubMed ID: 18710442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Survival analysis of surgically treated renal cell carcinoma: an analysis of 10-year data from single center].
    Zhang YS; Yu HY; Dong F; Li HZ
    Zhonghua Wai Ke Za Zhi; 2016 Jul; 54(7):528-33. PubMed ID: 27373480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.